| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 61.9K | $804K | $12.98 | Sep 10, 2024 | Direct |
| Travere Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Employee stock option (right to buy) | 91K | Jan 31, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Sep 10, 2024 | 1 | -$8.88K | 4 | Sep 10, 2024 | CHIEF MEDICAL OFFICER |
| TVTX | Travere Therapeutics, Inc. | Sep 5, 2024 | 2 | -$25.2K | 4 | Sep 9, 2024 | CHIEF MEDICAL OFFICER |
| TVTX | Travere Therapeutics, Inc. | Jan 31, 2024 | 3 | -$18.5K | 4 | Feb 2, 2024 | CHIEF MEDICAL OFFICER |
| TVTX | Travere Therapeutics, Inc. | Jan 3, 2024 | 2 | -$23.6K | 4 | Jan 5, 2024 | Chief Medical Officer |
| TVTX | Travere Therapeutics, Inc. | Jan 31, 2023 | 3 | $0 | 4 | Feb 2, 2023 | Chief Medical Officer |
| TVTX | Travere Therapeutics, Inc. | Jan 4, 2023 | 2 | -$51.7K | 4 | Jan 6, 2023 | Chief Medical Officer |
| TVTX | Travere Therapeutics, Inc. | Jan 31, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Medical Officer |
| TVTX | Travere Therapeutics, Inc. | Jan 1, 2022 | 2 | $0 | 4 | Jan 4, 2022 | Chief Medical Officer |
| TVTX | Travere Therapeutics, Inc. | Jan 1, 2022 | 0 | $0 | 3 | Jan 4, 2022 | Chief Medical Officer |